177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
Chongqing Peg-Bio Biopharm Co., Ltd.
Zhejiang Cancer Hospital
Boston Children's Hospital
Centre Henri Becquerel
Ottawa Hospital Research Institute
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Dartmouth-Hitchcock Medical Center
Hebei Medical University Fourth Hospital
University of Manitoba
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Hospices Civils de Lyon
Thomas Jefferson University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Utah
Centre Hospitalier Annecy Genevois
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Mario Negri Institute for Pharmacological Research
Peking University Cancer Hospital & Institute
Sir Run Run Shaw Hospital
Fudan University
Memorial Sloan Kettering Cancer Center
Sobi, Inc.
M.D. Anderson Cancer Center
Second Affiliated Hospital of Guangzhou Medical University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cairo University
OHSU Knight Cancer Institute
Cellphire Therapeutics, Inc.
Centre Hospitalier Universitaire de Saint Etienne
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Novartis
Emory University
University of Utah
Anhui Provincial Cancer Hospital
CTI BioPharma
University of Pittsburgh
Terumo BCTbio
Peking Union Medical College Hospital
Groupe Francophone des Myelodysplasies
Sun Yat-sen University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
PrECOG, LLC.
CTI BioPharma
Beijing Northland Biotech. Co., Ltd.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center